Petra Pharma Corp of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2019-04-26. The offering totals $13.3M, of which $13.3M was reported sold. Industry: Biotechnology.
Showing 25 of 35 people.
| Name | Role | Location |
|---|---|---|
| Barbara Dalton | Related Person | New York, NY |
| M. Johnston Erwin | Related Person | New York, NY |
| Jenna Foger | Related Person | New York, NY |
| Steve Gillis | Related Person | New York, NY |
| THONG LE | Related Person | Seattle, WA |
| David McElligott | Related Person | New York, NY |
| Brian O'Callaghan | Related Person | New York, NY |
| LINDSAY RAYLE | Related Person | New York, NY |
| David Renas | Related Person | New York, NY |
| David Schubert | Related Person | New York, NY |
| Paul Sekhri | Related Person | New York, NY |
| Albert Yu | Related Person | New York, NY |
| Steve Gillis | Director | New York, NY |
| THONG LE | Director | Seattle, WA |
| THONG LE | Executive Officer | Seattle, WA |
| THONG LE | Promoter | Seattle, WA |
| Asish Xavier | Director | South San Francisco, CA |
| M. Johnston Erwin | Director | New York, NY |
| Barbara Johnston Dalton | Director | New York, NY |
| Jenna Johnston Foger | Director | New York, NY |
| Paul Johnston Sekhri | Director | New York, NY |
| David Johnston McElligott | Executive Officer | New York, NY |
| David Johnston McElligott | Promoter | New York, NY |
| David Johnston Renas | Executive Officer | New York, NY |
| Albert Johnston Yu | Executive Officer | New York, NY |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2020-03-31 | D/A | $27.5M | $27.5M |
| 2019-10-21 | D/A | $23.0M | $20.0M |
| 2019-08-01 | D/A | $17.0M | $17.0M |
| 2018-09-13 | D | $10.0M | $10.0M |
| 2018-01-22 | D/A | $48.3M | $31.2M |
| 2017-01-04 | D/A | $48.3M | $21.2M |
| 2016-01-06 | D | $10.4M | $10.0M |